Aptevo therapeutics announces 1-for 37 reverse stock split as part of nasdaq compliance plan

Seattle, wa / accesswire / november 29, 2024 / aptevo therapeutics inc. (nasdaq:apvo) ("aptevo" or the "company"), today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-37 (the "reverse stock split"). the reverse stock split is expected to become effective on december [3], 2024 at 5:01 p.m.

NDAQ Ratings Summary

NDAQ Quant Ranking